Subrata Ghosh is the inaugural director of the Institute of Translational Medicine (ITM), Birmingham and Professor of Translational Medicine, University of Birmingham since June 2016. The Institute of Translational Medicine is a collaborative and ambitious organisation created by a partnership between University of Birmingham, University Hospitals Birmingham NHS Trust and the Birmingham Women and Children NHS Trust. The goal is to develop interdisciplinary research between basic science and translational research in life sciences as well as in engineering, artificial intelligence and computational biology. Strong collaborations have been built to promote interdisciplinary research, guide implementation through applied health research, patient engagement in translational research, human big data resources with a multitude of industry collaborations. He is the gastroenterology theme lead and executive committee member of the inaugural NIHR Biomedical Research Centre Birmingham. Prior to this he was the Professor and Chairman of Medicine, University of Calgary, Canada and Head of Medicine, Alberta Health Services, Calgary. Between 2002 and 2008 he was the Professor and Chair of gastroenterology at Imperial College London, Hammersmith Hospital and head of interventional medicine division of the Imperial College Hospitals NHS Trust. Prior to this he was consultant gastroenterologist and honorary senior lecturer at University of Edinburgh. He remains adjunct professor of medicine at University of Calgary Canada and sits on the President’s Visiting Committee of the University of Alberta, Canada for precision medicine signature project in Alberta between Alberta Universities and Alberta Health Services.
Subrata Ghosh is a Fellow of the Canadian Academy of Health Sciences and theme lead for Integration cluster of the International Organisation for Study of IBD (IOIBD). He has published over 440 manuscripts in international journals including New England Journal of Medicine, Lancet, Nature Medicine, Gastroenterology and Gut, and delivered over 700 international lectures including named lectures. His h index is currently 81. His research interests are precision medicine in IBD, immune cell plasticity, targeted immunotherapies in IBD, interaction of nutrients and immune system and innate immunity in IBD. He initiated the precision medicine signature project in Alberta Canada. He has been the recipient of multiple individual and large team grants from CIHR, AIHS, MRC, NIHR, Wellcome Trust, CCUK and CCC, as well as industry partnered research projects. He has served on numerous committees, councils and grant panels regionally, nationally and internationally, and been chief editor, associate editor and editorial board member of a number of international reputable journals.
Subrata Ghosh is very well connected internationally, both through personal research as well as strategic organisational links with institutions in North America, China, Europe and Japan. He remains clinically active and research active in interdisciplinary wet and dry laboratory projects.